 |
 |

Transfusion of Hepatitis B Surface Antigen—Positive PlasmaProphylaxis With Hepatitis B Immune Globulin
Massumeh Telischi, MD;
Mahin Ziyai, MD;
Frederick Steigmann, MD;
Chung Mei Ling, PhD
JAMA. 1980;244(20):2312-2313.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
A STUDY by Seeff and colleagues1 established the effectiveness of hepatitis B immune globulin (HBIG) for immune prophylaxis in persons exposed to known infectious inocula. Studies in other laboratories2-4 also showed effective protection by HBIG in preventing or delaying overt viral hepatitis B after accidental exposure to hepatitis B virus (HBV). Accordingly, prophylactic injection of HBIG for persons working in high-risk environments was recommended. The Public Health Service Advisory Committee on Immunization Practice recommended a two-dose schedule of HBIG treatments for individuals exposed to a single inoculum of hepatitis B surface antigen (HBsAg)-contaminated material.5 A study by Klein et al6 supported the two-dose schedule, rather than a single dose, when the initial dose of globulin was the same.
We describe a patient who was effectively treated with HBIG after being accidentally transfused with a unit of HBsAg-positive plasma. At the time we were not aware of a
. . . [Full Text PDF of this Article]
Author Affiliations
From the Blood Bank (Drs Telischi and Ziyai) and the Division of Gastroenterology (Dr Steigmann), Cook County Hospital, Chicago; and the Virology Laboratory, Abbott Laboratories, North Chicago (Dr Ling).
Footnotes
Reprint requests to Blood Bank, Cook County Hospital, 1825 W Harrison St, Chicago, IL 60612 (Dr Telischi).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|